copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Prostate-Specific Antigen (PSA) Test - NCI - National Cancer Institute What is the PSA test? Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland Both prostate cancer and several benign conditions (particularly benign prostatic hyperplasia, or BPH, and prostatitis) can cause PSA levels in the blood to rise
Understanding Prostate Changes - NCI - National Cancer Institute Learn about prostate changes and symptoms that are not cancer, plus risk factors and treatment for prostatitis, enlarged prostate (BPH), prostate cancer Talk with your doctor about prostate cancer screening tests (DRE, PSA)
Prostate Cancer Treatment - NCI PSA levels may also be high in men who have an infection or inflammation of the prostate or BPH (an enlarged, but noncancerous, prostate) PSMA PET scan: An imaging procedure that is used to help find prostate cancer cells that have spread outside of the prostate, into bone, lymph nodes, or other organs
Conversation on Prostate Cancer Prevention and Finasteride Because the decision to perform prostate biopsies during the study was based on PSA levels, this may have contributed to increased detection of prostate cancer, in general, and high-grade prostate cancer, in particular, among men receiving finasteride
PSMA PET-CT Accurately Detects Prostate Cancer Spread Under the approval, the tracer can be used in PET imaging for prostate cancer that is suspected of having spread to other parts of the body Ga 68 PSMA-11 can also be used in men who have been treated successfully for prostate cancer but, because of elevated PSA levels, their disease is suspected of having returned
Prostate Cancer Screening (PDQ®) - NCI Prostate cancer screening with the prostate-specific antigen (PSA) test or digital rectal exams has not been shown to reduce prostate cancer deaths Get detailed information about prostate cancer screening, including potential benefits and harms, in this summary for clinicians
Prostate Cancer Treatment (PDQ®) - NCI Prostate cancer treatment can include active surveillance, surgery, radiation therapy, hormonal therapy, chemotherapy, immunotherapy, and supportive care Get detailed treatment information for newly diagnosed and recurrent prostate cancer in this summary for clinicians
An Improved Prostate Cancer Biomarker Test May Help Men Avoid . . . Researchers funded by NCI have developed and validated a new prostate cancer urinary biomarker test that can help differentiate who should proceed for biopsy after an elevated prostate-specific antigen (PSA) test from those who can wait The 18-gene test, called MyProstateScore version 2 0, or MPS2, improves upon the earlier version of MyProstateScore (MPS), the validated two-gene algorithm
PSA Velocity Does Not Improve Prostate Cancer Detection A rapid increase in prostate-specific antigen (PSA) levels is not grounds for automatically recommending a prostate biopsy, according to a study published online February 24, 2011, in the Journal of the National Cancer Institute
Prostate Cancer, Nutrition, and Dietary Supplements - NCI CAM treatments have been studied to see if their use lowers the risk of prostate cancer, kills prostate cancer cells, or lowers the risk that cancer will come back after treatment Most of these studies used prostate-specific antigen (PSA) levels to find out whether the treatment worked This is a weaker measure of how well the treatment works than direct measures, such as fewer new cases of